Ira Duarte
Förmögenhet: 557 555 $ per 2026-06-30
Förmögenhet: 557 555 $ per 2026-06-30
Ira Duarte is currently an Independent Director at Terrascend Corp.
since 2022 and EVP, Chief Financial & Accounting Officer at Heron Therapeutics, Inc. starting in 2024.
Former positions include Chief Financial Officer & VP-Controller at Veloxis Pharmaceuticals A from 2018 to 2023, Controller at BioDelivery Sciences International, Inc. from 2014 to 2016, Director-Accounting & Financial Planning at Chiesi USA, Inc. from 2009 to 2013, and Senior Manager at Ernst & Young A. Education includes undergraduate studies at Florida Atlantic University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
TERRASCEND CORP. 0,21 % | 2026-06-30 | 657 930 ( 0,21 % ) | 446 077 $ | 2026-06-30 |
HERON THERAPEUTICS INC 0,14 % | 2026-06-16 | 261 073 ( 0,14 % ) | 111 478 $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| TERRASCEND CORP. | Direktör/Styrelseledamot | 2022-12-02 |
| HERON THERAPEUTICS, INC. | Finansdirektör/CFO | 2023-06-16 |
| Företag | Position | Slut |
|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Finansdirektör/CFO | 2023-01-01 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Comptroller/Controller/Revisor | 2016-01-01 |
| CORNERSTONE THERAPEUTICS, INC. | Comptroller/Controller/Revisor | 2013-10-01 |
Ernst & Young A/S
Ernst & Young A/S Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 7 |
|---|---|
Heron Therapeutics, Inc.
Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the prevention of organ rejection in kidney transplant patients | Health Technology |
Florida Atlantic University
Florida Atlantic University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernst & Young A/S
Ernst & Young A/S Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Cornerstone Therapeutics, Inc.
Cornerstone Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for hospital and specialty care areas including respiratory, rare diseases & critical care | Health Technology |
Terrascend Corp.
Terrascend Corp. Agricultural Commodities/MillingProcess Industries Produces and sells medical cannabis products | Process Industries |
Välj din utgåva
All finansiell information anpassad till den nationella nivån